Global Phenylketonuria (PKU) Market Study 2015-2025, by Segment (Medications, Supplements, Others), by Market (Household, HospitalSupplements, Others), by Company (Biomarin, Vitaflo, Mead Johnson)

ReportPage
Report ID
16751
Published Date
27-Sep
No of Report Page
71
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $3,600.00
US $3,600.00
US $1,800.00

  • Report Details

    Snapshot
    Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weig

    More...
  • Table Of Content

    Table of Content
    1 Industry Overview
    1.1 Phenylketonuria (PKU) Industry
    1.1.1 Overview
    1.1.2 Products of Major Companies
    1.2 Market Segment
    1.2.1 Industry Chain
    1.2.2 Consumer Distribution
    1.3 Price & Cost Overview
    2 Phenylketonuria (PKU) Market by Type
    2.1 By Type
    2.1.1 Medications
    2.1.2 Supplements
    2.1.3 Others
    2.2 Market S

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample